Our Real World Reach

At Adelphi Real World, we are driven to expand the reach of scientific knowledge for the benefit of patients everywhere. Across all areas of our business and across all disease areas we cover, we actively engage with physicians, patients and their caregivers to ensure our research is appropriate and valuable.

If you are interested in learning more about our programmes, or engaging as part of our research, please contact us.

We provide a unique range of real-world insights involving physicians, patients, caregivers and payers; with insights achieved through our market-leading Disease Specific Programmes™, tailored non-interventional studies, international secondary database analyses and expert market access strategy.

Adelphi Real World is a dedicated team of more than 200 professionals; we provide support and guidance for our clients across all areas of real-world evidence implementation.

Our scope of work and experience covers the complete lifecycle of a compound. Our global coverage ensures our evidence can shape all levels of insight from multi-country strategy through to domestic, tactical implementation.

We provide a unique range of real-world insights involving physicians, patients, caregivers and payers; with insights achieved through our market-leading Disease Specific Programmes™, tailored non-interventional studies, international secondary database analyses and expert market access strategy.

Adelphi Real World is a dedicated team of more than 200 professionals; we provide support and guidance for our clients across all areas of real-world evidence implementation.

Our scope of work and experience covers the complete lifecycle of a compound. Our global coverage ensures our evidence can shape all levels of insight from multi-country strategy through to domestic, tactical implementation.

Our specialist teams engage with physicians, patients, caregivers and key opinion leaders to ensure that our research represents real world practice.

We conduct real world evidence data collection around the globe, and are able to analyse these data collectively for true country comparisons.

Our active research programmes cover the following therapeutic areas:

AUTOIMMUNE

ONCOLOGY

RARE DISEASE

CVRM

CNS

RESPIRATORY

WOMEN’S HEALTH

OPHTHALMOLOGY

INFECTIOUS DISEASE

One of the teams created by the Scientific Advisory Board is the Adelphi Real World Fieldwork Review Team. All Disease Specific Programmes (DSPs) are submitted for review by the Fieldwork Review Team during their design phase. The team’s remit is to ensure all DSPs meet the highest standards of design so that a high level of quality and consistency of data collection is achieved across all of our research.

Please use the form below to search through our publications